Memorial Hospital Research Laboratories

The Nai-Kong Cheung Lab

Research

The Nai-Kong Cheung Lab
Nai-Kong V. Cheung, MD, PhD
Enid A. Haupt Chair in Pediatric Oncology, Pediatrics

My lab focuses on engineering antibodies and immune cells to treat both solid tumors and liquid tumors in children.

View Lab Overview

Nai-Kong Cheung Lab Group

Publications

People

The Nai-Kong Cheung Lab

Nai-Kong V. Cheung, MD, PhD

Enid A. Haupt Chair in Pediatric Oncology, Pediatrics

  • Physician-scientist Nai-Kong Cheung focuses on engineering antibodies and immune cells to treat both solid tumors and liquid tumors in children.
  • MD, PhD (Immunology), Harvard Medical School
cheungn@mskcc.org
Email Address
646-888-2313
Office Phone
View physician profile
Physician profile

Members

Irene Cheung, ScD
Irene Cheung

Laboratory Member and Attending Clinical Immunologist

Madelyn Espinosa-Cotton
Madelyn Espinosa-Cotton

Research Fellow

Yi Feng
Yi Feng

Senior Research Assistant

Hong-fen Guo
Hong-fen Guo

Research Assistant/Specialist

Sayed Shahabuddin (Shahab) Hoseini
Sayed Shahabuddin (Shahab) Hoseini

Visiting Investigator

Tsung-Yi (Steven) Lin, PhD
Tsung-Yi (Steven) Lin

Research Fellow

Alan Long, PhD
Alan Long

Research Scholar

Aiza Malik
Aiza Malik

Research Technician

Jeong Park
Jeong A Park

Research Fellow

Mauricio Rendon-Bernot, MD
Mauricio Rendon-Bernot

Clinical Fellow

Brian Santich
Brian H. Santich

Research Fellow

Hoa Tran
Hoa Tran

Senior Research Assistant

Linlin  Wang , PhD
Linlin Wang

Research Associate

Mao (Sally) Wang, PhD
Mao (Sally) Wang

Research Fellow

Hong Xu
Hong Xu

Senior Research Scientist

Lab Affilations

Open Positions

Career Opportunities

Immunotherapy of Human Solid and Liquid Tumors A postdoctoral basic research position is now open for the study of antibody-based immunotherapy in both human solid and liquid tumors.

Apply now

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Nai-Kong V. Cheung discloses the following relationships and financial interests:

  • Abpro Inc
    Intellectual Property Rights; Ownership / Equity Interests; Provision of Services (uncompensated)
  • Alex’s Lemonade Stand Foundation
    Provision of Services
  • Biotec Pharmacon
    Intellectual Property Rights
  • Eureka Therapeutics Inc
    Ownership / Equity Interests; Provision of Services (uncompensated)
  • Keystone Symposia
    Provision of Services
  • Partner Therapeutics, Inc.
    Provision of Services
  • St. Jude-VIVA Forum
    Provision of Services
  • Y-mAbs Therapeutics, Inc.
    Intellectual Property Rights; Ownership / Equity Interests

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures